Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

PRADEEP A CHANDRA

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1124225347
CMS profile
5951
Location
BRIDGETON, MO

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$2,342.75

114 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,742.75 113
Consulting Fee $600.00 1

By paying entity

PY2023 · entire year · sorted by reported total

Page 3 of 3; records 101–114 of 114 matching records. This page contains 14 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

PRADEEP A CHANDRA

NPI 1124225347 · CMS profile ID 5951

Allopathic & Osteopathic Physicians / Internal Medicine / Cardiovascular Disease

BRIDGETON, MO

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–114 of 114 matching records. This page contains 14 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1124225347?year=2023&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
PRADEEP A CHANDRA, NPI 1124225347, CMS profile ID 5951. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–114 of 114 matching records. This page contains 14 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1124225347?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). PRADEEP A CHANDRA, NPI 1124225347, CMS profile ID 5951. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–114 of 114 matching records. This page contains 14 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1124225347?year=2023&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
PRADEEP A CHANDRA, NPI 1124225347, CMS profile ID 5951, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–114 of 114 matching records. This page contains 14 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1124225347?year=2023&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

114 matching records · $2,342.75 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 114 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–114 of 114.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
E.R. Squibb & Sons, L.L.C. $20.1802/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015813335 CMS
Corcept Therapeutics $24.6702/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050824837 CMS
Novo Nordisk Inc $13.4202/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002520691 CMS
Merck Sharp & Dohme LLC $13.1602/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048693531 CMS
Novo Nordisk Inc $19.8202/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002520727 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $20.9701/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997010767 CMS
Daiichi Sankyo Inc. $17.4201/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006381093 CMS
Amgen Inc. $19.6501/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020057381 CMS
Novartis Pharmaceuticals Corporation $11.4901/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991748443 CMS
Novartis Pharmaceuticals Corporation $17.6501/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991748435 CMS
Novartis Pharmaceuticals Corporation $0.9101/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991748439 CMS
PFIZER INC. $22.7801/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050690127 CMS
Novo Nordisk Inc $16.7801/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002520703 CMS
Corcept Therapeutics $24.6701/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050824811 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $42,350.89 152
PY2020 $1,031.89 76
PY2021 $2,880.29 121
PY2022 $4,423.33 105
PY2023 $2,342.75 114
PY2024 $1,209.36 69
PY2025 $1,056.51 62

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2021 Principal investigator $40,549.00 50
PY2020 Principal investigator $7,120.00 12
PY2019 Principal investigator $40,663.11 2

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

50 records in PY2021

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Boehringer Ingelheim International GmbH $833.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339757
Principal investigator 1 Boehringer Ingelheim International GmbH $1,173.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339759
Principal investigator 1 Boehringer Ingelheim International GmbH $431.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339761
Principal investigator 1 Boehringer Ingelheim International GmbH $833.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339791
Principal investigator 1 Boehringer Ingelheim International GmbH $431.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339793
Principal investigator 1 Boehringer Ingelheim International GmbH $1,173.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339795
Principal investigator 1 Boehringer Ingelheim International GmbH $833.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339797
Principal investigator 1 Boehringer Ingelheim International GmbH $986.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339799
Principal investigator 1 Boehringer Ingelheim International GmbH $833.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339801
Principal investigator 1 Boehringer Ingelheim International GmbH $431.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339805
Principal investigator 1 Boehringer Ingelheim International GmbH $431.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339807
Principal investigator 1 Boehringer Ingelheim International GmbH $176.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339809
Principal investigator 1 Boehringer Ingelheim International GmbH $1,173.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339811
Principal investigator 1 Boehringer Ingelheim International GmbH $833.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339813
Principal investigator 1 Boehringer Ingelheim International GmbH $833.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339893
Principal investigator 1 Boehringer Ingelheim International GmbH $1,173.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339895
Principal investigator 1 Boehringer Ingelheim International GmbH $1,173.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339911
Principal investigator 1 Boehringer Ingelheim International GmbH $1,173.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339913
Principal investigator 1 Boehringer Ingelheim International GmbH $431.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339915
Principal investigator 1 Boehringer Ingelheim International GmbH $431.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339917
Principal investigator 1 Boehringer Ingelheim International GmbH $431.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339919
Principal investigator 1 Boehringer Ingelheim International GmbH $431.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339921
Principal investigator 1 Boehringer Ingelheim International GmbH $431.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339923
Principal investigator 1 Boehringer Ingelheim International GmbH $176.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339925
Principal investigator 1 Boehringer Ingelheim International GmbH $1,173.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339927
Principal investigator 1 Boehringer Ingelheim International GmbH $1,173.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339929
Principal investigator 1 Boehringer Ingelheim International GmbH $833.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339931
Principal investigator 1 Boehringer Ingelheim International GmbH $833.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339933
Principal investigator 1 Boehringer Ingelheim International GmbH $833.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339935
Principal investigator 1 Boehringer Ingelheim International GmbH $833.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339937
Principal investigator 1 Boehringer Ingelheim International GmbH $833.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339939
Principal investigator 1 Boehringer Ingelheim International GmbH $833.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339941
Principal investigator 1 Boehringer Ingelheim International GmbH $833.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339943
Principal investigator 1 Boehringer Ingelheim International GmbH $431.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339945
Principal investigator 1 Boehringer Ingelheim International GmbH $1,173.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339949
Principal investigator 1 Boehringer Ingelheim International GmbH $833.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339951
Principal investigator 1 Boehringer Ingelheim International GmbH $833.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339953
Principal investigator 1 Boehringer Ingelheim International GmbH $833.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339955
Principal investigator 1 Boehringer Ingelheim International GmbH $833.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339957
Principal investigator 1 Boehringer Ingelheim International GmbH $833.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339959
Principal investigator 1 Boehringer Ingelheim International GmbH $833.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339961
Principal investigator 1 Boehringer Ingelheim International GmbH $833.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339963
Principal investigator 1 Boehringer Ingelheim International GmbH $833.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339965
Principal investigator 1 Boehringer Ingelheim International GmbH $833.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339967
Principal investigator 1 Boehringer Ingelheim International GmbH $833.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339969
Principal investigator 1 Boehringer Ingelheim International GmbH $1,173.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339971
Principal investigator 1 Boehringer Ingelheim International GmbH $1,173.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339973
Principal investigator 1 Boehringer Ingelheim International GmbH $1,173.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339975
Principal investigator 1 Boehringer Ingelheim International GmbH $833.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339977
Principal investigator 1 Boehringer Ingelheim International GmbH $833.00 04/08/2021 Non-covered Recipient Entity
St Louis Heart And Vascular
Empagliflozin and heart failure (HFpEF) No dispute reported 06/30/2026 828339979